---

**From:** Molly Cabrera <liucarrie@example.net>  
**To:** Brendan Gordon <brenthorne@example.org>  
**Subject:** Request for Input on Risk Assessment Visuals for Q4 Presentation  

Hi Brendan,

I hope this email finds you well. I'm in the process of finalizing the visual assets for our upcoming Q4 Risk Assessment Presentation scheduled for November 15th. Given the technical nature of the data, I want to ensure that the graphics effectively communicate the key risk metrics without oversimplifying the complexities involved.

Could you take a look at the draft slides attached and let me know if the visualizations align with the risk factors you’ve highlighted? Your insights would be invaluable, especially regarding the new regulatory compliance risks.

Also, if there are any specific data points or trends you think should be emphasized, please let me know. I can make adjustments on my end to ensure we’re accurately representing the data in a way that supports your analysis.

I appreciate your help with this and look forward to your feedback.

Best,  
Molly Cabrera  
Graphic Designer  
Merck & Co., Inc.  
Phone: (212) 555-0193  

---

**From:** Brendan Gordon <brenthorne@example.org>  
**To:** Molly Cabrera <liucarrie@example.net>  
**Subject:** Re: Request for Input on Risk Assessment Visuals for Q4 Presentation  

Hi Molly,

Thanks for reaching out. I had a chance to review the draft slides you sent over. Overall, they look great and definitely capture the essence of our risk assessment findings. The trend lines on slide 3 are particularly effective at illustrating the potential impact of the upcoming regulatory changes.

I do have a couple of suggestions:

1. On slide 5, could we add a comparison chart showing historical compliance issues versus projected risks? This might give the audience a clearer understanding of how the new regulations could affect our operations.
2. The color scheme on slide 7 could be adjusted for better clarity; perhaps use a sharper contrast to differentiate between the risk levels.

Let me know if you need any additional data or if there's a good time to discuss this over the phone. I should be available most of the day tomorrow, barring any last-minute meetings.

Thanks for your hard work on this. I’m confident our presentation will be well-received.

Best,  
Brendan Gordon  
Risk Analyst  
Merck & Co., Inc.  
Phone: (212) 555-0248  

---